# Curative Biotechnology, Inc. (CUBT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CUBT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -979.2K | $ -535.0K | $ 1.36M | $ -6.39M |
| 2025 | $ 0 | $ -2.30M | $ -889.6K | $ 1.36M | $ -6.09M |
| 2024 | $ 0 | $ -3.55M | $ -1.09M | $ 1.37M | $ -4.91M |
| 2023 | $ 0 | $ -4.28M | $ -541.3K | $ 2.26M | $ -3.14M |
| 2022 | $ 0 | $ -6.26M | $ -1.80M | $ 1.07M | $ -20.53M |
| 2021 | $ 0 | $ -6.35M | $ -1.93M | N/A | $ -16.36M |
| 2020 | $ 0 | $ -5.95M | $ -242.2K | $ 559.8K | $ -4.52M |
| 2019 | $ 0 | $ 428.5K | $ -11.3K | $ 0 | $ -357.3K |
| 2014 | $ 29.0K | $ -69.4K | $ -48.9K | $ 255.7K | $ -742.9K |
| 2013 | $ 460.4K | $ -89.8K | $ -109.5K | $ 260.7K | $ -704.3K |
| 2012 | $ 193.5K | $ -442.2K | N/A | N/A | N/A |
| 2011 | $ 234.8K | $ -722.1K | N/A | N/A | N/A |
| 2010 | $ 75.6K | $ -358.9K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.21 |
| Liabilities / Eq | -1.34 |
| Current Ratio | 0.02 |

## Other views

- [Metrics](https://sponda.capital/en/CUBT.md)
- [Charts](https://sponda.capital/en/CUBT/charts.md)
- [Compare](https://sponda.capital/en/CUBT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.